Post by
HighSkies2019 on Sep 11, 2020 10:11am
here's the limk
https://tcbiznews.com/news/19081/non-union-fractures-market-to-eyewitness-massive-growth-by-2026-leading-key-players-daniel-c-allisonregenexxkalytera-therapeutics-inc-asa-srlmesentech/#
Comment by
JMark80 on Sep 11, 2020 11:04am
LMAO. Kalytera terminated that indication, among many others, 2 years ago.
Comment by
JMark80 on Sep 11, 2020 2:12pm
GvHD, Acute Respiratory Distress Syndrome, Ulcerative Colitis, Psoriasis, Dysmenorrhea, Uveitis, Pain, Osteoporosis, Osteogenesis Imperfecta, Atopic Dermatitis, Acne. Am I missing any? LMAO
Comment by
JMark80 on Sep 11, 2020 2:16pm
Oh wait, I am! Anyone remember K-1052, the Inducible Nitric Oxide Synthase Inhibitor for Sepsis Associated Renal Failure & Severe Traumatic Brain Injury? Of course you don't! LMAO